目的:探讨依托考昔联合秋水仙碱治疗急性痛风性关节炎的疗效及对患者血尿酸、肾功能和炎性因子的影响。方法:选择杭州市第三人民医院2018年1月至2019年6月收治的急性痛风性关节炎患者60例为研究对象，按照随机数字表法分为治疗组30例与对照组30例。对照组患者给予秋水仙碱治疗，治疗组在对照组基础上联合依托考昔治疗。两组疗程均为7 d。比较两组疗效、治疗前后关节肿胀和关节压痛积分、血尿酸、肾功能和炎性因子水平变化。结果:治疗组总有效率(90.00%)高于对照组(63.33%)，差异有统计学意义(χn 2＝5.963，n P0.05). The ESR [(15.21±3.04)mm/h], CRP [(7.06±1.04)mg/L] and IL-1β [(4.17±0.76)pg/mL] in the treatment group were lower than those in the control group [(21.98±3.64)mm/h, (10.94±1.26)mg/L and (6.28±1.08)pg/mL] (n t=7.819, 13.008 and 8.751, all n P<0.05).n Conclusion:The therapeutic effect of etocoxib combined with colchicine on acute gouty arthritis is obvious, but it has no significant effect on the blood uric acid and renal function, and it can reduce the inflammatory reaction.